Harvard Bioscience: Tools to Advance Life Science Research and Regenerative Medicine
 
Click on these icons to download or listen to our latest investor information:  


Investor Relations
 
Investor Presentation
Annual Report
Latest Live Presentation
Earnings Call
Print Page
Email Page
 
Our History Our Mission Financial Performance Business Model
Directions to Harvard Bioscience Investor Contact About Harvard Bioscience

Press Releases


All Releases
View Summary Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEO
May 15, 2013
PDF 9.8 KB Add to Briefcase
View Summary HBIO Reports First Quarter 2013 Results
May 2, 2013
PDF 36.3 KB Add to Briefcase
View Summary HBIO Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. and Announces Its Intended Path Forward
May 1, 2013
PDF 11.0 KB Add to Briefcase
View Summary Webcast Now Available of Press Conference Discussing Landmark Surgery Involving Harvard Bioscience's Synthetic Trachea Scaffold and "InBreath" Bioreactor
Apr 30, 2013
PDF 13.5 KB Add to Briefcase
View Summary Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold and Bioreactor Used in First U.S. Transplant of a Regenerated Trachea
Apr 30, 2013
PDF 14.9 KB Add to Briefcase
View Summary Harvard Bioscience to Participate in Press Conference Today to Discuss Landmark Surgery
Apr 30, 2013
PDF 11.3 KB Add to Briefcase
View Summary Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call for May 2, 2013
Apr 26, 2013
PDF 12.5 KB Add to Briefcase
View Summary HBIO Announces Postponement of the IPO for Harvard Apparatus Regenerative Technology, Inc.
Apr 9, 2013
PDF 10.2 KB Add to Briefcase
View Summary HBIO Announces Filing of Request for Acceleration of Effectiveness for Harvard Apparatus Regenerative Technology, Inc.'s IPO Registration Statement
Apr 2, 2013
PDF 11.5 KB Add to Briefcase
View Summary Harvard Bioscience, Inc. Announces Receipt of Private Letter Ruling and Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. Following Its Initial Public Offering
Mar 25, 2013
PDF 12.6 KB Add to Briefcase
View Summary HBIO Reports Fourth Quarter 2012 Results
Feb 28, 2013
PDF 48.9 KB Add to Briefcase
View Summary Harvard Bioscience, Inc. Schedules Fourth Quarter 2012 Conference Call for February 28, 2013
Feb 25, 2013
PDF 12.8 KB Add to Briefcase
View Summary Harvard Bioscience, Inc. Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology, Inc.
Dec 11, 2012
PDF 13.7 KB Add to Briefcase
View Summary HBIO Reports Third Quarter 2012 Results
Nov 1, 2012
PDF 46.4 KB Add to Briefcase
View Summary Harvard Bioscience, Inc. Schedules Third Quarter 2012 Conference Call for November 1, 2012
Oct 26, 2012
PDF 12.8 KB Add to Briefcase
View Summary HBIO President David Green to Present at the UBS 2012 Global Life Sciences Conference
Sep 13, 2012
PDF 11.6 KB Add to Briefcase
View Summary HBIO Reports Second Quarter 2012 Revenue Growth of 5% Over Second Quarter 2011
Aug 2, 2012
PDF 46.4 KB Add to Briefcase
View Summary Harvard Bioscience, Inc. Schedules Second Quarter 2012 Conference Call for August 2, 2012
Jul 19, 2012
PDF 12.6 KB Add to Briefcase
View Summary Harvard Bioscience's "InBreath" Bioreactors Used in World's First Successful Regenerated Laryngotracheal Transplants
Jun 26, 2012
PDF 141.7 KB Add to Briefcase
View Summary HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011
May 3, 2012
PDF 38.7 KB Add to Briefcase
Showing 1-20 of 240 Page: 1 2 3 ... 12  Next 20
=add release to Briefcase


Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.


Privacy Policy   |   Terms and Conditions
Copyright©2013 Harvard Bioscience, Inc. All rights reserved.
1-800-272-2775   1-508-893-8999